Chronic Granulomatous Disease: an Updated Experience, with Emphasis on Newly Recognized Features
Zacharoula Oikonomopoulou1, Stanford Shulman1,2, Marilyn Mets1,3
1Division of Infectious Diseases, Ann & Robert H Lurie Children's Hospital of Chicago, 225 E Chicago Ave., Box 20, Chicago, IL, 60611, USA.
Insights
Chronic granulomatous disease (CGD) is a rare immune disorder. This study updates US experience with CGD, noting a reduced infection rate and newly recognized features like unusual infections and autoimmune issues.
Area of Science:
- Immunology
- Genetics
- Infectious Diseases
Background:
- Chronic granulomatous disease (CGD) is an uncommon, inherited immune deficiency.
- Understanding its clinical spectrum and management is crucial for patient outcomes.
Purpose of the Study:
- To update a large, single-center US experience with CGD.
- To identify and describe newly recognized features of the disease.
Main Methods:
- Retrospective review of 26 CGD patients from November 2013 to December 2019.
- Analysis of infectious agents, serious infection rates, and clinical manifestations.
Main Results:
- Reduced serious infection rate (0.2/patient-year) compared to previous periods.
- Identified unusual infections (e.g., Pneumocystis pneumonia, basidiomycete pneumonia) and autoimmune manifestations (e.g., retinitis pigmentosa).
- Two of four evaluated patients successfully underwent stem cell transplantation with no deaths.
Conclusions:
- This update highlights a decreased infection burden in CGD patients.
- Newly recognized features expand the understanding of CGD's diverse clinical presentation.
Purpose:
Chronic granulomatous disease (CGD) is an uncommon, inborn error of immunity. We updated our large, single-center US experience with CGD and describe some newly recognized features.
Methods:
We retrospectively reviewed 26 patients seen from November 2013 to December 2019. Serious infections required intravenous antibiotics or hospitalization.
Results:
There were 21 males and 5 females. The most frequent infectious agents at presentation were aspergillus (4), serratia (4), burkholderia (2), Staphylococcus aureus (2), and klebsiella (2). The most common serious infections at presentation were pneumonia (6), lymphadenitis (6), and skin abscess (3). Our serious infection rate was 0.2 per patient-year from December 2013 through November 2019, down from 0.62 per patient-year from the previous study period (March 1985-November 2013). In the last 6 years, four patients were evaluated for human stem cell transplantation, two were successfully transplanted, and we had no deaths. Several patients had unusual infections or autoimmune manifestations of disease, such as pneumocystis pneumonia, basidiomycete/phellinus fungal pneumonia, and retinitis pigmentosa. We included one carrier female with unfavorable Lyonization in our cohort.
Conclusion:
We update of a large US single-center experience with CGD and describe some recently identified features of the illness.
More Related Videos
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-I: Introduction
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
